Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 10:12:610330.
doi: 10.3389/fneur.2021.610330. eCollection 2021.

Tau Pathology and Adult Hippocampal Neurogenesis: What Tau Mouse Models Tell us?

Affiliations
Review

Tau Pathology and Adult Hippocampal Neurogenesis: What Tau Mouse Models Tell us?

Sarah Houben et al. Front Neurol. .

Abstract

Adult hippocampal neurogenesis (AHN) has been widely confirmed in mammalian brains. A growing body of evidence points to the fact that AHN sustains hippocampal-dependent functions such as learning and memory. Impaired AHN has been reported in post-mortem human brain hippocampus of Alzheimer's disease (AD) and is considered to contribute to defects in learning and memory. Neurofibrillary tangles (NFTs) and amyloid plaques are the two key neuropathological hallmarks of AD. NFTs are composed of abnormal tau proteins accumulating in many brain areas during the progression of the disease, including in the hippocampus. The physiological role of tau and impact of tau pathology on AHN is still poorly understood. Modifications in AHN have also been reported in some tau transgenic and tau-deleted mouse models. We present here a brief review of advances in the relationship between development of tau pathology and AHN in AD and what insights have been gained from studies in tau mouse models.

Keywords: Alzheimer's disease; dentate gyrus; neurogenesis; tau; tauopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A–C) Representative photos of tau pathology detected in the DG of post-mortem brain section of a 65-year-old male AD patient (Braak VI). Tau pathology was detected by anti-total tau B19 antibody (9) (A), anti-phospho Ser396/404 tau PHF1 antibody (10) (B), or by Gallyas silver staining (11) (C). (D) Representative photo of tau pathology detected by PHF1 in the DG of 12-month-old tau Tg30 mice (12). ML, molecular layer; GCL, granule cell layer; SGZ, subgranular zone. (E) Specific markers for five different stages of AHN in the dentate gyrus of the hippocampus. GFAP, glial fibrillary acidic protein; BLBP, brain lipid-binding protein; SOX2, SRY (sex determining region Y)-box 2; DCX, doublecortin; 3R tau, tau with 3 repeats of microtubule-binding sequences; NeuN, neuronal nuclei; 4R tau, tau with 4 repeats of microtubule-binding sequences. (F) Schematic representation of the human 6 isoforms of tau protein. Exon 2, 3, and 10 (E2, E3, and E10, respectively) are alternatively spliced. Alternative splicing leads to 0, 1 or 2 inserts near amino terminus (0N, 1N, or 2N, respectively) and 3 or 4 repeats (3R or 4R, respectively) of microtubule-binding sequences near carboxyl terminus. The shortest 0N3R isoform is predominantly detected in immature neurons of fetal brains and of adult hippocampus. While only 4R isoforms are principally expressed in adult mouse brains, all the 6 isoforms are expressed in adult human brains. (G) Immunostaining of immature neurons by anti-3R tau RD3 antibody (Merck Millipore #05-803) in the dentate gyrus of the hippocampus in a 12-month-old wild-type mouse. (H) Functional involvement of tau at different stages of AHN. Hematoxylin counterstaining for (A–D,G). Detailed protocol on histological analyses is available in (12). Scale bars: 25 μm.

Similar articles

Cited by

References

    1. Wong CW, Quaranta V, Glenner GG. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci USA. (1985) 82:8729–32. 10.1073/pnas.82.24.8729 - DOI - PMC - PubMed
    1. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. (1984) 120:885–90. 10.1016/S0006-291X(84)80190-4 - DOI - PubMed
    1. Brion JP, Passareiro H, Nunez J, Flament-Durand J. Mise en évidence immunologique de la protéine tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d'Alzheimer. Arch Biol. (1985) 95:229–35.
    1. Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. . Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. (2012) 71:362–81. 10.1097/NEN.0b013e31825018f7 - DOI - PMC - PubMed
    1. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev. (2000) 33:95–130. 10.1016/S0165-0173(00)00019-9 - DOI - PubMed

LinkOut - more resources